Tag: Medication
-
A pharma giant is moving past one patent cliff — but another is already looming
Disappointing data highlights Novartis’ challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.
-
Workers and researchers see benefits in GLP-1 access. Companies are weighing the costs
As GLP-1 use reaches new highs, more employers are grappling with whether the benefits of covering these medications justify their high costs.
-
Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.
-
Fact vs. fiction: Doctors share whether peptides are safe and effective
As peptides gain popularity among some wellness influencers and federal government officials, doctors share what you need to know.
-
Doctors call Moderna, Merck cancer vaccine data a major advancement — despite Wall Street reaction
Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful result for melanoma patients who underwent surgery.
-
Moderna shares plunge after leak of cancer vaccine data despite positive results
Moderna’s stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.
-
New bipartisan bill aims to speed up clinical trials for rare disease treatments
A new bipartisan bill aims to speed rare disease drug development by making clinical trials faster, cheaper and more accessible to patients.
-
Novo’s next-generation obesity drug shows 25% weight loss in women in late-stage analysis
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
-
Three mindfulness exercises that take just 30 seconds: Do them ‘waiting for the microwave to ring’ or ‘sitting at a stoplight,’ says psychologist
When it comes to mindfulness, all you need is 30 seconds, says psychologist and author Eli Susman.
-
Sickle cell gene therapies offer new hope, but access remains a major challenge
FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access have slowed their use.
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany india Investment strategy iran Iran war markets People per politics return russia S&P 500 Index said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
